Drug for treatment and postoperative care of uterus myoma
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for uterine fibroids and drugs, applied in the direction of antineoplastic drugs, drug combinations, and pharmaceutical formulas, to achieve good curative effect and wide application range
Inactive Publication Date: 2013-03-20
潘玉梅
View PDF2 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Ultrasound therapy and radiation therapy have a strict scope of application, and there are certain risks. Generally, patients under the age of 40 should avoid using them
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0047] The raw material composition and the weight of active ingredient of medicine of the present invention are:
[0052] The processing steps of the pharmaceutical preparation method of the present invention are:
[0053] (1) Grind fried mustard ears, chuanxiong, and peach kernels into powder, pass through 120 mesh fine powder, and set aside.
[0054] (2) Steam the raw rhubarb thoroughly, grind it into powder, pass through 120 mesh fine powder, and set aside.
[0055] (3) Mix the Scutellaria baicalensis with Jimo old wine, stir-fry it with a slow fire and grind it into powder, pass it into a fine powder of 120 mesh, and set aside.
[0056...
Embodiment 2
[0061] The raw material composition and the weight of active ingredient of medicine of the present invention are:
[0066] The process steps, usage and dosage of the medicine preparation method in this embodiment are the same as those in Example 1.
[0067] clinical information:
[0068] Through clinical verification, the drug of the present invention has a total effective rate of 68.24% for intramural fibroids, 71.32% for subserosal fibroids, and 62.85% for submucosal fibroids , the total effective rate for cervical fibroids is 82.14%, and the total effective rate for multiple uterine fibroids is 83.49%, which fully meets the effective rate ...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a drug for treatment and postoperative care of uterus myoma, and belongs to the field of traditional Chinese medicines. The effective constituents of the drug comprise the following raw materials in parts by weight: 70-90 parts of white atractylodes rhizome, 60-80 parts of angelica, 55-75 parts of codonopsis pilosula, 50-70 parts of fried schizonepeta spike, 45-60 parts ofcortex moutan, 40-55 parts of cassia twig, 35-50 parts of white paeony root, 30-45 parts of herba leonuri, 25-43 parts of ligusticum wallichii, 22-40 parts of peach kernel, 18-35 parts of rhizoma sparganii, 15-30 parts of raw rhubarb, 12-25 parts of curcuma zedoary, 8-20 parts of scutellaria baicalensis, 5-16 parts of poria cocos and 3-12 parts of radix cyathulae. According to the invention, the raw materials are reasonably mixed, the raw materials capable of promoting blood circulation to remove blood stasis, resolving hard lump, warming, activating meridian and tonifying vital energy and spleen are selected for pathogenic factors such as cold congealing stasis, spleen deficiency and damp obstruction, dried blood accumulation, uterus stasis and the like; the effects of finding a disease source by visiting and treating both symptoms and root causes are achieved by regulating the whole-body function and activating the immune system of a patient; and the drug has a very good treatment effect for intramural myoma, subserous myoma, submucous myoma and cervix myoma through clinic verification.
Description
Technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a medicine for treating uterine fibroids and postoperative care. Background technique [0002] Uterine fibroids, also known as uterine leiomyomas, are the most common benign tumors of female genitalia. Most of them have no obvious symptoms. It causes pain, and if treatment is delayed, it can lead to female infertility, miscarriage, frequent urination, dysuria and other hazards, which is a major killer of women's health. According to the location of fibroids, there are four common types of uterine fibroids: intramural fibroids, submucosal fibroids, subserosal fibroids and cervical fibroids. [0003] Uterine fibroids can cause pelvic congestion and infection. After the subserosal fibroid pedicle is twisted, intestinal adhesions will occur, which will be infected by intestinal bacteria, or free fibroids will be formed due to the twisting of the tumor pedicle. Uterine fi...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more